Skip to main content
Erschienen in: Breast Cancer Research 2/2005

01.06.2005 | Poster Presentation

Essential functions of the Janus kinase 2 (Jak2) during mammary gland development and tumorigenesis

verfasst von: K Sakamoto, A Krempler, AA Triplett, J Zhu, H Rui, K-U Wagner

Erschienen in: Breast Cancer Research | Sonderheft 2/2005

Einloggen, um Zugang zu erhalten

Excerpt

Jak2 is a hormone-receptor-coupled kinase that mediates the tyrosine phosphorylation and activation of signal transducers and activators of transcription (Stat). The biological relevance of Jak/Stat signaling in hormone-responsive adult tissues is difficult to investigate since Jak2 deficiency leads to embryonic lethality [13]. We therefore generated various Jak2 conditional knockout models to study essential functions of Jak2 during particular stages of mammary gland development and during neoplastic transformation in a Her2/neu-overexpressing breast cancer model. Our experiments show that Jak2 is essential for mammogenesis in virgin, pregnant, and postpartum females [4]. In addition to its pivotal role for mammary epithelial cell proliferation, specification, and differentiation, we demonstrate that this kinase is indispensable for the prolactin-mediated activation of Stat5 and the maintenance of functionally differentiated alveolar cells during lactation. A primary focus of our current research is to examine how Jak/Stat signaling cascades are altered in breast cancer models that initiate tumorigenesis through overexpression of growth factor receptors, in particular ErbB2 (Her2/neu). The uniqueness of our model design enables us to genetically modify Jak/Stat signaling both prior to growth factor-mediated neoplastic transformation (cancer prevention) and during particular stages of the progressing disease (cancer therapy). …
Literatur
1.
Zurück zum Zitat Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, et al: Jak2 is essential for signaling through a variety of cytokine receptors. Cell. 1998, 93: 385-395. 10.1016/S0092-8674(00)81167-8.CrossRefPubMed Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, et al: Jak2 is essential for signaling through a variety of cytokine receptors. Cell. 1998, 93: 385-395. 10.1016/S0092-8674(00)81167-8.CrossRefPubMed
2.
Zurück zum Zitat Neubauer H, Cumano A, Muller M, Wu H, Huffstadt U, Pfeffer K: Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell. 1998, 93: 397-409. 10.1016/S0092-8674(00)81168-X.CrossRefPubMed Neubauer H, Cumano A, Muller M, Wu H, Huffstadt U, Pfeffer K: Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell. 1998, 93: 397-409. 10.1016/S0092-8674(00)81168-X.CrossRefPubMed
3.
Zurück zum Zitat Krempler A, Qi Y, Triplett AA, Zhu J, Rui H, Wagner KU: Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice. Genesis. 2004, 40: 52-57. 10.1002/gene.20063.CrossRefPubMed Krempler A, Qi Y, Triplett AA, Zhu J, Rui H, Wagner KU: Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice. Genesis. 2004, 40: 52-57. 10.1002/gene.20063.CrossRefPubMed
4.
Zurück zum Zitat Wagner KU, Krempler A, Triplett AA, Qi Y, George NM, Zhu J, Rui H: Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Mol Cell Biol. 2004, 24: 5510-5520. 10.1128/MCB.24.12.5510-5520.2004.CrossRefPubMedPubMedCentral Wagner KU, Krempler A, Triplett AA, Qi Y, George NM, Zhu J, Rui H: Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Mol Cell Biol. 2004, 24: 5510-5520. 10.1128/MCB.24.12.5510-5520.2004.CrossRefPubMedPubMedCentral
Metadaten
Titel
Essential functions of the Janus kinase 2 (Jak2) during mammary gland development and tumorigenesis
verfasst von
K Sakamoto
A Krempler
AA Triplett
J Zhu
H Rui
K-U Wagner
Publikationsdatum
01.06.2005
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe Sonderheft 2/2005
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1125

Weitere Artikel der Sonderheft 2/2005

Breast Cancer Research 2/2005 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.